Prognostic value of PD-L1 and PD-1 expression in upper tract urothelial carcinoma patients. Luca Campedel , Eva Compérat , Géraldine Cancel-Tassin , Justine Varinot , Christian Pfister , Clara Delcourt , Françoise Gobet , Mathieu Roumiguié , Pierre-Marie Patard , Gwendoline Daniel , Pierre Bigot , Julie Carrouget , Caroline Eymerit , Stéphane Larré , Priscilla Léon , Anne Durlach , Alain Ruffion , Emilien Seizilles de Mazancourt , Myriam Decaussin-Petrucci , Thomas Bessède , Cédric Lebacle , Sophie Ferlicot , Grégoire Robert , Nam-Son Vuong , Magali Philip , Sébastien Crouzet , Xavier Matillon , Florence Mège-Lechevallier , Hervé Lang , Pascal Mouracade , Véronique Lindner , Paul Gougis , Olivier Cussenot , Morgan Rouprêt , Thomas Seisen BJU international（2023）
摘要
We observed that PD-L1 and PD-1 expression were both associated with adverse pathological features that translated into an independent and cumulative adverse prognostic value in UTUC patients treated with RNU.
更多 查看译文
AI 理解论文
溯源树
样例
